Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Titel:
Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Auteur:
Eichenbaum, David A. Holekamp, Nancy Khanani, Arshad M. Pieramici, Dante Hershberger, Vrinda Sheth, Veeral Brunstein, Flavia Ma, Ling Zou, Yixuan Indjeian, Vahan B. Dere, Randall Maia, Mauricio Hsu, Joy C. Gao, Simon S. Yaspan, Brian Willis, Jeffrey R. Wiley, Henry Lai, Phillip Chen, Hao